We selected CD81—one of the two genes independently associated with overall survival in glioblastoma patients according to the Gene Expression Profiling Interactive Analysis (GEPIA) server (Figure 8C)—for subsequent functional validation (the P of CD81 is smaller). The gene discussed is CD81; the disease is glioblastoma.